March 27, 2020

Anti-hypertensive Angiotensin II receptor blockers associated to mitigation of disease severity in elderly COVID-19 patients.

Category: Article Summary

Topic: Clinical Characteristics and Health Care Setting

• Findings from this retrospective study of 511 COVID-19 patients suggest that elderly (age 65+) patients with hypertension (HT) who are taking ARB anti-HT drugs may be less likely to develop severe lung disease when compared to patients taking no anti-HT drugs.

Liu et al. (Mar 27, 2020). Anti-hypertensive Angiotensin II receptor blockers associated to mitigation of disease severity in elderly COVID-19 patients. Pre-print downloaded Mar 27 from https://doi.org/10.1101/2020.03.20.20039586